Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
This is her 5th battle with Covid in the past 2 years despite having original vaccinations; This is her 5th battle with Covid in the past 2 years despite having original vaccinations; Today is the ninth day of this bout and is still experiencing a bad headache; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "This is her 5th battle with Covid in the past 2 years despite having original vaccinations"; HEADACHE (non-serious), outcome "unknown", described as "Today is the ninth day of this bout and is still experiencing a bad headache". Therapeutic measures were taken as a result of covid-19, drug ineffective. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. Clinical Course: The reporter expressed sincere gratitude for the generous help in providing Paxlovid for their daughter. The daughter had experienced her fifth episode of COVID 19 in the past two years despite having received the original vaccinations. On the ninth day of this bout, she was still experiencing a severe headache.The reporter inquired about any nearby studies on long term COVID or emotional support for her. This was considered a potential adverse event report for a non phone case.